{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T11:05:01Z","timestamp":1788001501053,"version":"build-2784847793"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"Introduction<\/jats:title>Pulmonary exacerbations (PEx) in persons with cystic fibrosis (CF) are primarily related to acute or chronic inflammation associated with bacterial lung infections, which may be caused by several bacteria that activate similar bacterial genes and produce similar by-products. The goal of our study was to perform a stratified functional analysis of bacterial genes at three distinct time points in the treatment of a PEx in order to determine the role that specific airway microbiome community members may play within each clinical state (i.e., PEx, end of antibiotic treatment, and follow-up). Our secondary goal was to compare the change between clinical states with the metabolic activity of specific airway microbiome community members.<\/jats:p><\/jats:sec>Methods<\/jats:title>This was a prospective observational study of persons with CF treated with intravenous antibiotics for PEx between 2016 and 2020 at Children\u2019s National Hospital. Demographic and clinical information as well as respiratory samples were collected at hospital admission for PEx, end of antibiotic treatment, and follow-up. Metagenomic sequencing was performed; MetaPhlAn3 and HUMANn3 were used to assign sequences to bacterial species and bacterial metabolic genes, respectively.<\/jats:p><\/jats:sec>Results<\/jats:title>Twenty-two persons with CF, with a mean age of 14.5 (range 7\u201323) years, experienced 45 PEx during the study period. Two-hundred twenty-one bacterial species were identified in the respiratory samples from the study cohort. Ten bacterial species had differential gene abundance across changes in the clinical state including Staphylococcus aureus<\/jats:italic>, Streptococcus salivarius<\/jats:italic>, and Veillonella atypica<\/jats:italic> (all padj &lt; 0.01 and log2FoldChange &gt; |2|). These corresponded to a differential abundance of bacterial genes, with S. aureus<\/jats:italic> accounting for 81% of the genes more abundant in PEx and S. salivarius<\/jats:italic> accounting for 83% of the genes more abundant in follow-up, all compared to the end of treatment. Lastly, 8,653 metabolic pathways were identified across samples, with again S. aureus<\/jats:italic> and S. salivarius<\/jats:italic> contributing to the differential abundance of pathways (106 in PEx vs. 66 in follow-up, respectively). V. atypica<\/jats:italic> was associated with a single metabolic pathway (UDP-N<\/jats:italic>-acetyl-D<\/jats:sc>-glucosamine biosynthesis) increased in follow-up compared to PEx.<\/jats:p><\/jats:sec>Discussion<\/jats:title>Taken together, these data suggest that the metabolic potential of bacterial species can provide more insight into changes across clinical states than the relative abundance of the bacteria alone.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.1082125","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T09:22:37Z","timestamp":1673256157000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Using metabolic potential within the airway microbiome as predictors of clinical state in persons with cystic fibrosis"],"prefix":"10.3389","volume":"9","author":[{"given":"Gabriella","family":"Shumyatsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aszia","family":"Burrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hollis","family":"Chaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"Sami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastassios C.","family":"Koumbourlis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Freishtat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A.","family":"Crandall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith T.","family":"Zemanick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,9]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis.","volume":"388","author":"Elborn","year":"2016","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1056\/NEJMra1300109","article-title":"Origins of cystic fibrosis lung disease.","volume":"372","author":"Stoltz","year":"2015","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nm.2715","article-title":"Cystic fibrosis: a mucosal immunodeficiency syndrome.","volume":"18","author":"Cohen","year":"2012","journal-title":"Nat Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1164\/rccm.200812-1845PP","article-title":"Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations.","volume":"180","author":"Flume","year":"2009","journal-title":"Am J Respir Crit Care Med."},{"key":"B5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrg3849","article-title":"Cystic fibrosis genetics: from molecular understanding to clinical application.","volume":"16","author":"Cutting","year":"2015","journal-title":"Nat Rev Genet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/ismej.2015.198","article-title":"Respiratory microbiota resistance and resilience to pulmonary exacerbation and subsequent antimicrobial intervention.","volume":"10","author":"Cuthbertson","year":"2016","journal-title":"ISME J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1513\/AnnalsATS.201211-107OC","article-title":"Changes in cystic fibrosis airway microbiota at pulmonary exacerbation.","volume":"10","author":"Carmody","year":"2013","journal-title":"Ann Am Thorac Soc."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0194060","article-title":"Fluctuations in airway Bacterial communities associated with clinical states and disease stages in cystic fibrosis.","volume":"13","author":"Carmody","year":"2018","journal-title":"PLoS One."},{"key":"B9","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1093\/jpids\/piac036","article-title":"Exploring the cystic fibrosis lung microbiome: making the most of a sticky situation.","volume":"11","author":"Thornton","year":"2022","journal-title":"J Pediatr Infect Dis Soc."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00174","article-title":"Longitudinal associations of the cystic fibrosis airway microbiome and volatile metabolites: a case study.","volume":"10","author":"Hahn","year":"2020","journal-title":"Front Cell Infect Microbiol."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.896439","article-title":"Metabolomic biomarkers to predict and diagnose cystic fibrosis pulmonary exacerbations: a systematic review.","volume":"10","author":"Nguyen","year":"2022","journal-title":"Front Pediatr."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-38984-y","article-title":"Changes in microbiome diversity following beta-lactam antibiotic treatment are associated with therapeutic versus subtherapeutic antibiotic exposure in cystic fibrosis.","volume":"9","author":"Hahn","year":"2019","journal-title":"Sci Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1136\/jim-2021-001824","article-title":"Importance of beta-lactam pharmacokinetics and pharmacodynamics on the recovery of microbial diversity in the airway of persons with cystic fibrosis.","volume":"69","author":"Hahn","year":"2021","journal-title":"J Investig Med."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e04104","article-title":"Airway microbial diversity is decreased in young children with cystic fibrosis compared to healthy controls but improved with CFTR modulation.","volume":"6","author":"Hahn","year":"2020","journal-title":"Heliyon."},{"key":"B15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41390-021-01419-4","article-title":"Inflammation in children with cystic fibrosis: contribution of Bacterial production of long-chain fatty acids.","volume":"90","author":"Felton","year":"2021","journal-title":"Pediatr Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1093\/bioinformatics\/btx330","article-title":"Flexbar 3.0 - SIMD and multicore parallelization.","volume":"33","author":"Roehr","year":"2017","journal-title":"Bioinformatics."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1093\/bioinformatics\/btx754","article-title":"BioBakery: a meta\u2019omic analysis environment.","volume":"34","author":"McIver","year":"2018","journal-title":"Bioinformatics."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.65088","article-title":"Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with biobakery 3.","volume":"10","author":"Beghini","year":"2021","journal-title":"eLife."},{"key":"B19","doi-asserted-by":"crossref","first-page":"D633","DOI":"10.1093\/nar\/gkx935","article-title":"The metacyc database of metabolic pathways and enzymes.","volume":"46","author":"Caspi","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"B21","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-24277-4","author":"Wickham","year":"2016","journal-title":"ggplot2: elegant graphics for data analysis."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061217","article-title":"Phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data.","volume":"8","author":"McMurdie","year":"2013","journal-title":"PLoS One."},{"key":"B23","author":"Oksanen","year":"2017","journal-title":"vegan: community ecology package. R package version 24-4."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1093\/bioinformatics\/bty895","article-title":"Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences.","volume":"35","author":"Zhu","year":"2019","journal-title":"Bioinformatics."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-017-0237-y","article-title":"Normalization and microbial differential abundance strategies depend upon data characteristics.","volume":"5","author":"Weiss","year":"2017","journal-title":"Microbiome."},{"key":"B26","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.4049\/jimmunol.1600279","article-title":"The lung microbiome, immunity, and the pathogenesis of chronic lung disease.","volume":"196","author":"O\u2019Dwyer","year":"2016","journal-title":"J Immunol."},{"key":"B27","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/MCP.0000000000000299","article-title":"The role of anaerobic bacteria in the cystic fibrosis airway.","volume":"22","author":"Sherrard","year":"2016","journal-title":"Curr Opin Pulm Med."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126980","article-title":"Reduced Bacterial colony count of anaerobic bacteria is associated with a worsening in lung clearance index and inflammation in cystic fibrosis.","volume":"10","author":"O\u2019Neill","year":"2015","journal-title":"PLoS One."},{"key":"B29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/1040841X.2018.1549019","article-title":"Anaerobes in cystic fibrosis patients\u2019 airways.","volume":"45","author":"Lamoureux","year":"2019","journal-title":"Crit Rev Microbiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1164\/rccm.200708-1151OC","article-title":"Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis.","volume":"177","author":"Tunney","year":"2008","journal-title":"Am J Respir Crit Care Med."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00767-15","article-title":"Pediatric cystic fibrosis sputum can be chemically dynamic, anoxic, and extremely reduced due to hydrogen sulfide formation.","volume":"6","author":"Cowley","year":"2015","journal-title":"MBio."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00242-2018","article-title":"Anaerobic bacteria cultured from cystic fibrosis airways correlate to milder disease: a multisite study.","volume":"52","author":"Muhlebach","year":"2018","journal-title":"Eur Respir J."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-85592-w","article-title":"An observational study of anaerobic bacteria in cystic fibrosis lung using culture dependant and independent approaches.","volume":"11","author":"Lamoureux","year":"2021","journal-title":"Sci Rep."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2017.00106","article-title":"In vivo and In vitro interactions between Pseudomonas aeruginosa and Staphylococcus spp.","volume":"7","author":"Hotterbeekx","year":"2017","journal-title":"Front Cell Infect Microbiol."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020773","article-title":"Synergetic fermentation of glucose and glycerol for high-yield N-acetylglucosamine production in Escherichia coli.","volume":"23","author":"Wang","year":"2022","journal-title":"Int J Mol Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1128\/AAC.01218-09","article-title":"Delineation of a Bacterial starvation stress response network which can mediate antibiotic tolerance development.","volume":"54","author":"Fung","year":"2010","journal-title":"Antimicrob Agents Chemother."},{"key":"B37","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1126\/science.1211037","article-title":"Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria.","volume":"334","author":"Nguyen","year":"2011","journal-title":"Science."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101740","article-title":"N-Acetyl-D-glucosamine acts as adjuvant that Re-sensitizes starvation-induced antibiotic-tolerant population of E. Coli to \u03b2-lactam.","volume":"23","author":"Wang","year":"2020","journal-title":"iScience."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1164\/rccm.202003-0735OC","article-title":"Polyclonality, shared strains, and convergent evolution in chronic cystic fibrosis Staphylococcus aureus airway infection.","volume":"203","author":"Long","year":"2021","journal-title":"Am J Respir Crit Care Med."},{"key":"B40","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jcf.2011.06.002","article-title":"Review: Staphylococcus aureus and MRSA in cystic fibrosis.","volume":"10","author":"Goss","year":"2011","journal-title":"J Cyst Fibros."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10091177","article-title":"Staphylococcus aureus and cystic fibrosis\u2014a close relationship. What can we learn from sequencing studies?","volume":"10","author":"Rumpf","year":"2021","journal-title":"Pathogens."},{"key":"B42","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1128\/CMR.00069-15","article-title":"Clinical significance and pathogenesis of Staphylococcal small colony variants in persistent infections.","volume":"29","author":"Kahl","year":"2016","journal-title":"Clin Microbiol Rev."},{"key":"B43","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/978-3-031-08491-1_15","article-title":"Mixed populations and co-infection: Pseudomonas aeruginosa and Staphylococcus aureus.","volume":"1386","author":"Camus","year":"2022","journal-title":"Adv Exp Med Biol."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.617784","article-title":"How Bacterial adaptation to cystic fibrosis environment shapes interactions between Pseudomonas aeruginosa and Staphylococcus aureus.","volume":"12","author":"Camus","year":"2021","journal-title":"Front Microbiol."},{"key":"B45","article-title":"Airway epithelium dysfunction in cystic fibrosis and COPD.","volume":"2018","author":"De Rose","year":"2018","journal-title":"Mediators Inflamm."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0040037","article-title":"Nucleotide biosynthesis is critical for growth of bacteria in human blood.","volume":"4","author":"Samant","year":"2008","journal-title":"PLoS Pathog."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022","article-title":"Surviving the host: microbial metabolic genes required for growth of Pseudomonas aeruginosa in physiologically-relevant conditions.","volume":"13","author":"Belanger","year":"2022","journal-title":"Front Microbiol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1128\/JB.00115-19","article-title":"The yin and yang of Streptococcus lung infections in cystic fibrosis: a model for studying polymicrobial interactions.","volume":"201","author":"Scott","year":"2019","journal-title":"J Bacteriol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.meegid.2014.10.001","article-title":"Genomics of Streptococcus salivarius, a major human commensal.","volume":"33","author":"Delorme","year":"2015","journal-title":"Infect Genet Evol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1082125\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T09:22:48Z","timestamp":1673256168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1082125\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,9]]},"references-count":49,"alternative-id":["10.3389\/fmed.2022.1082125"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.1082125","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,9]]},"article-number":"1082125"}}